Since the introduction of alglucosidase alfa, the number of reported cases has shown an increasing trend year by year, with a transient decline in 2020, which may be related to the shortage of drugs during the coronavirus disease 2019 outbreak.
← all excerpts
A Real-World Data Analysis of Alglucosidase Alfa in the FDA Adverse Event Reporting System (FAERS) Database.
1
—
—